What is the Summit?
An intimate, high-impact gathering for healthcare leaders who want to make Precision Medicine a reality

Genetics offers enormous promise for human health, and for enabling transformative change in our healthcare system. However, the practical barriers to integrating genetics into clinical care delivery are undeniable. Because genetics is inherently data-intensive, critical challenges relate to the data and digital infrastructure that span across research, care delivery, and payment.

At the Genetic Health Information Network Summit, 100 top leaders from across healthcare, genetics, and technology gather to discuss critical improvements to the systems connecting genetic information in healthcare. The group, which includes CEOs, CMOs, CMIOs, Department Chairs, Research Directors, Managing Directors, Professors, Policymakers, and Patient Advocates, comes together for a candid, solution-oriented discussion on how to collectively overcome the barriers to achieving precision medicine at scale.

If this meeting sounds of interest to you, the organizers would be pleased to provide a 20-minute briefing about the meeting, format, and participant base to help you determine whether it’s a good match for your interests and goals.

If you would like to learn more, please complete the form. A meeting organizer will contact you to arrange a briefing.

Request a Briefing

Topics of Focus

For a sample of the topics covered at the Summit, download this whitepaper, which details the five core issues that emerged from the 2017 event:

  1. Genetic testing laboratory quality and patient safety;
  2. Clinical validity, utility, and value assessment at scale;
  3. Genetic test identification for market tracking, evidence-gathering, billing, and payment;
  4. Provider education, communication, and support at the point-of-care; and
  5. Patient access and control of genetic data.

Complete the form to download the paper.

Download the Paper

Past Organizers, Speakers & Authors

Titles and organizational affiliations may be reflective of the time of the event and may have since changed.

CARLOS BUSTAMANTE, PhD
Chair, Department of Biomedical Data Science
Stanford University

MARA ASPINALL
CEO
Health Catalysts Group

GILLIAN HOOKER, PhD, ScM, LCGC
VP, Clinical Development
Concert Genetics

SUZANNE BELINSON, PhD, MPH
VP, Commercial Markets
Tempus

ROBERT NUSSBAUM, MD
Chief Medical Officer
Invitae

DEE ANNA SMITH
CEO
Sarah Cannon

GEORGE CARDOZA
Senior Vice President, Chief Financial Officer
NeoGenomics

SEAN HOFHERR, PhD
Chief Scientific Officer
GeneDx, Inc.

JULIE M EGGINGTON, MS, PhD
Co-founder & CEO
Center for Genomic Interpretation

GERALD FELDMAN, MD, PhD
President
American College of Medical Genetics & Genomics

MARY FREIVOGEL, MS, CGC
President
National Society of Genetic Counselors

ERYNN GORDON, MS, LCGC
VP, Clinical Operations
Genome Medical

NIKOLETTA SIDIROPOULOS, MD
Medical Director, Genomic Medicine, Department of Pathology and Laboratory Medicine
University of Vermont Health Network

BAS VAN DER BAAN
Chief Clinical Officer
Agendia

HOWARD LEVY, MD, PhD
Associate Professor of Medicine
Johns Hopkins Medicine

LEE N. NEWCOMER, MD, MHA
SVP, Oncology and Genetics
UnitedHealthcare

BENJAMIN SOLOMON, MD, FACMG
Managing Director
GeneDx

ROBERT C. GREEN, MD, MPH
Director, Genomes2People
Division of Genetics at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School

DAN RODEN, MD
Senior Vice President, Personalized Medicine
Vanderbilt University Medical Center

NICOLE BOICE
Founder & CEO
Global Genes

DAVID MCCALLIE, MD
SVP, Medical Informatics
Cerner

EDWARD ABRAHAMS, PhD
President
Personalized Medicine Coalition

TAHA KASS-HOUT, MD
Former 1st Chief Health Informatics Officer
U.S. Food and Drug Administration (FDA)

GIL ALTEROVITZ, PhD
Director, Biomedical Cybernetics Laboratory
Harvard Medical School

KRISTINE BORDENAVE, MD
Corporate Medical Director
Humana

JOSHUA DENNY, MD
Professor of Biomedical Informatics and Medicine
Vanderbilt University

HENRY GARLICH
Director, Healthcare Value Solutions & Enhanced Clinical Programs
Blue Shield of California

TRENT HAYWOOD, MD, JD
SVP & Chief Medical Officer
Blue Cross Blue Shield Association

KATHRYN LANG, MD
Global Medical Strategy Head of Data Science
Pfizer

MATT MIGHT, PhD
Director, Hugh Kaul Personalized Medicine Institute
University of Alabama at Birmingham

LAURIE MCGRAW
SVP, Health Solutions
American Medical Association

VICTORIA PRATT, PhD
President
Association for Molecular Pathology

DAWN BARRY
Co-Founder and President
Luna DNA

ELI CASDIN
Chief Investment Officer
Casdin Capital

ELLEN MATLOFF, MS, CGC
President & CEO
My Gene Counsel

JULIE RAMAGE
National Accounts Director, Diagnostics
Pfizer

ALEX DE WINTER
Managing Director
GE Ventures

NICK NACLERIO, PhD
Founding Partner
Illumina Ventures

EMILY EDELMAN, MS, CGC
Associate Director of Clinical & Continuing Education
The Jackson Laboratory

JAMES O’LEARY
Chief Innovation Officer
Genetic Alliance

BRYCE OLSON
Global Marketing Director, Health and Life Sciences
Intel